These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29507419)

  • 1. EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.
    Li Z; Takenobu H; Setyawati AN; Akita N; Haruta M; Satoh S; Shinno Y; Chikaraishi K; Mukae K; Akter J; Sugino RP; Nakazawa A; Nakagawara A; Aburatani H; Ohira M; Kamijo T
    Oncogene; 2018 May; 37(20):2714-2727. PubMed ID: 29507419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.
    Wang C; Liu Z; Woo CW; Li Z; Wang L; Wei JS; Marquez VE; Bates SE; Jin Q; Khan J; Ge K; Thiele CJ
    Cancer Res; 2012 Jan; 72(1):315-24. PubMed ID: 22068036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
    Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
    EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
    Yang Q; Tian Y; Ostler KR; Chlenski A; Guerrero LJ; Salwen HR; Godley LA; Cohn SL
    BMC Cancer; 2010 Jun; 10():286. PubMed ID: 20546602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA XIST facilitates cell growth, migration and invasion via modulating H3 histone methylation of DKK1 in neuroblastoma.
    Zhang J; Li WY; Yang Y; Yan LZ; Zhang SY; He J; Wang JX
    Cell Cycle; 2019 Aug; 18(16):1882-1892. PubMed ID: 31208278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity.
    Bate-Eya LT; Gierman HJ; Ebus ME; Koster J; Caron HN; Versteeg R; Dolman MEM; Molenaar JJ
    Eur J Cancer; 2017 Apr; 75():63-72. PubMed ID: 28214660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
    Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
    Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.
    Yi X; Guo J; Guo J; Sun S; Yang P; Wang J; Li Y; Xie L; Cai J; Wang Z
    Sci Rep; 2017 Jun; 7(1):3568. PubMed ID: 28620234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
    Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
    J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PRC2 molecule EED is a target of epigenetic therapy for neuroblastoma.
    Shaliman D; Takenobu H; Sugino RP; Ohira M; Kamijo T
    Eur J Cell Biol; 2022; 101(3):151238. PubMed ID: 35636260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3.
    Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X
    Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.
    Chen L; Alexe G; Dharia NV; Ross L; Iniguez AB; Conway AS; Wang EJ; Veschi V; Lam N; Qi J; Gustafson WC; Nasholm N; Vazquez F; Weir BA; Cowley GS; Ali LD; Pantel S; Jiang G; Harrington WF; Lee Y; Goodale A; Lubonja R; Krill-Burger JM; Meyers RM; Tsherniak A; Root DE; Bradner JE; Golub TR; Roberts CW; Hahn WC; Weiss WA; Thiele CJ; Stegmaier K
    J Clin Invest; 2018 Jan; 128(1):446-462. PubMed ID: 29202477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Functional Characterization of a New Splicing Variant of EZH2 in the Central Nervous System.
    Li D; Wang HL; Huang X; Gu X; Xue W; Xu Y
    Int J Biol Sci; 2019; 15(1):69-80. PubMed ID: 30662348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
    Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
    Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide transcriptional profiling analysis reveals annexin A6 as a novel EZH2 target gene involving gastric cellular proliferation.
    Qi Y; Zhang X; Kang Y; Wu J; Chen J; Li H; Guo Y; Liu B; Shao Z; Zhao X
    Mol Biosyst; 2015 Jul; 11(7):1980-6. PubMed ID: 25947258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
    Duraisamy AJ; Mishra M; Kowluru RA
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6440-6448. PubMed ID: 29261844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
    Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
    Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures.
    Qadeer ZA; Valle-Garcia D; Hasson D; Sun Z; Cook A; Nguyen C; Soriano A; Ma A; Griffiths LM; Zeineldin M; Filipescu D; Jubierre L; Chowdhury A; Deevy O; Chen X; Finkelstein DB; Bahrami A; Stewart E; Federico S; Gallego S; Dekio F; Fowkes M; Meni D; Maris JM; Weiss WA; Roberts SS; Cheung NV; Jin J; Segura MF; Dyer MA; Bernstein E
    Cancer Cell; 2019 Nov; 36(5):512-527.e9. PubMed ID: 31631027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.
    Ochiai H; Takenobu H; Nakagawa A; Yamaguchi Y; Kimura M; Ohira M; Okimoto Y; Fujimura Y; Koseki H; Kohno Y; Nakagawara A; Kamijo T
    Oncogene; 2010 May; 29(18):2681-90. PubMed ID: 20190806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.